Charlebois ED - Search Results

1

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.

Johnson JL, Hadad DJ, Boom WH, Daley CL, Peloquin CA, Eisenach KD, Jankus DD, Debanne SM, Charlebois ED, Maciel E, Palaci M, Dietze R. Johnson JL, et al. Among authors: charlebois ed. Int J Tuberc Lung Dis. 2006 Jun;10(6):605-12. Int J Tuberc Lung Dis. 2006. PMID: 16776446 Clinical Trial.

2

Elevated HIV seroprevalence and risk behavior among Ugandan TB suspects: implications for HIV testing and prevention.

Srikantiah P, Lin R, Walusimbi M, Okwera A, Luzze H, Whalen CC, Boom WH, Havlir DV, Charlebois ED. Srikantiah P, et al. Among authors: charlebois ed. Int J Tuberc Lung Dis. 2007 Feb;11(2):168-74. Int J Tuberc Lung Dis. 2007. PMID: 17263287 Free PMC article.

3

Tuberculosis treatment in HIV infected Ugandans with CD4 counts>350 cells/mm reduces immune activation with no effect on HIV load or CD4 count.

Mahan CS, Walusimbi M, Johnson DF, Lancioni C, Charlebois E, Baseke J, Chervenak KA, Mugerwa RD, Havlir DV, Mayanja-Kizza H, Whalen CC, Boom WH; Uganda-Case Western Research Collaboration. Mahan CS, et al. PLoS One. 2010 Feb 22;5(2):e9138. doi: 10.1371/journal.pone.0009138. PLoS One. 2010. PMID: 20179751 Free PMC article. Clinical Trial.

4

Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Lancioni CL, Mahan CS, Johnson DF, Walusimbi M, Chervenak KA, Nalukwago S, Charlebois E, Havlir D, Mayanja-Kizza H, Whalen CC, Boom WH. Lancioni CL, et al. J Infect Dis. 2011 Apr 1;203(7):992-1001. doi: 10.1093/infdis/jiq141. J Infect Dis. 2011. PMID: 21402550 Free PMC article. Clinical Trial.

5

A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.

Nanteza MW, Mayanja-Kizza H, Charlebois E, Srikantiah P, Lin R, Mupere E, Mugyenyi P, Boom WH, Mugerwa RD, Havlir DV, Whalen CC. Nanteza MW, et al. J Infect Dis. 2011 Sep 15;204(6):884-92. doi: 10.1093/infdis/jir503. J Infect Dis. 2011. PMID: 21849285 Free PMC article. Clinical Trial.

6

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.

Srikantiah P, Walusimbi MN, Kayanja HK, Mayanja-Kizza H, Mugerwa RD, Lin R, Charlebois ED, Boom WH, Whalen CC, Havlir DV. Srikantiah P, et al. Among authors: charlebois ed. AIDS. 2007 Sep 12;21(14):1972-4. doi: 10.1097/QAD.0b013e32823ecf6e. AIDS. 2007. PMID: 17721107 Free PMC article.

7

Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.

Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV. Srikantiah P, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):458-60. doi: 10.1097/QAI.0b013e31817e9fb4. J Acquir Immune Defic Syndr. 2008. PMID: 19011423 Free PMC article. No abstract available.

8

Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.

Chamie G, Luetkemeyer A, Walusimbi-Nanteza M, Okwera A, Whalen CC, Mugerwa RD, Havlir DV, Charlebois ED. Chamie G, et al. Among authors: charlebois ed. Int J Tuberc Lung Dis. 2010 Oct;14(10):1295-302. Int J Tuberc Lung Dis. 2010. PMID: 20843421 Free PMC article.

9

Household ventilation and tuberculosis transmission in Kampala, Uganda.

Chamie G, Wandera B, Luetkemeyer A, Bogere J, Mugerwa RD, Havlir DV, Charlebois ED. Chamie G, et al. Among authors: charlebois ed. Int J Tuberc Lung Dis. 2013 Jun;17(6):764-70. doi: 10.5588/ijtld.12.0681. Int J Tuberc Lung Dis. 2013. PMID: 23676159

10

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Oyugi JH, et al. Among authors: charlebois ed. J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1100-2. doi: 10.1097/00126334-200408150-00014. J Acquir Immune Defic Syndr. 2004. PMID: 15247564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters